Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000359081 | SCV000399398 | uncertain significance | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000512905 | SCV000608787 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4, BS1 |
Gene |
RCV000512905 | SCV000731151 | likely benign | not provided | 2020-07-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29228253, 28622062) |
Invitae | RCV000512905 | SCV002395471 | likely benign | not provided | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278467 | SCV002565400 | uncertain significance | Ehlers-Danlos syndrome | 2022-07-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002392875 | SCV002671726 | benign | Cardiovascular phenotype | 2019-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003940261 | SCV004752740 | likely benign | ZNF469-related disorder | 2022-08-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |